ULBP2, a ligand of NKG2D, is associated with poor prognosis in a number of human cancers, and surface expression of this protein is often lost in many human cancer cell types during NK cell-mediated cytolysis [20–22]. The gene discussed is ULBP2; the disease is cancer.